The intricate process of pharmaceutical manufacturing relies on a consistent supply of high-quality chemical intermediates. Among these, 1-(3,4-Dimethylphenyl)-3-methyl-3-pyrazolin-5-one, known by its CAS number 18048-64-1, plays a significant role. This compound is a vital intermediate in the synthesis of Eltrombopag, a crucial drug used in managing low platelet counts. For R&D scientists and procurement managers, understanding the value and sourcing of this chemical is paramount.

When you aim to buy 1-(3,4-dimethylphenyl)-3-methyl-3-pyrazolin-5-one, you are essentially acquiring a critical piece for Eltrombopag production. The chemical’s specifications, including its appearance as a white crystalline powder and a high assay (≥98.0%), underscore its suitability for pharmaceutical applications. Engaging with a reputable Eltrombopag intermediate supplier in China ensures that these standards are met consistently.

The demand for reliable manufacturers in China for such intermediates is high. Pharmaceutical companies need assurance of supply chain stability and product quality. A trusted supplier of 18048-64-1 will not only provide competitive 18048-64-1 intermediate price but also demonstrate robust quality control measures. This is crucial for scaling up production efficiently.

For businesses looking to source this vital compound, identifying a high purity C12H14N2O manufacturer that aligns with pharmaceutical industry standards is key. The application of this intermediate directly impacts the efficacy and safety of the final Eltrombopag API, making supplier selection a strategic decision.

In essence, the role of 1-(3,4-Dimethylphenyl)-3-methyl-3-pyrazolin-5-one (CAS 18048-64-1) in pharmaceutical manufacturing cannot be overstated. By carefully selecting your supplier and focusing on quality and reliability, you can ensure the smooth progression of your Eltrombopag development and production. NINGBO INNO PHARMCHEM CO.,LTD. is committed to being your trusted source for this essential pharmaceutical intermediate.